SCHEMBL7089683

SCHEMBL7089683

Cc1ccc(C2CC2N)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
KDM1A O60341 15/20 0.45
KCNH2 Q12809 4/20 0.44
KDM1B Q8NB78 3/20 0.44
MAOB P27338 3/20 0.44
MAOA P21397 1/20 0.44
RCOR1 Q9UKL0 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8134479 1.00 CYP3A4 (0.45) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL7001620 1.00 CYP3A4 (0.45) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL7001619 1.00 CYP3A4 (0.45) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL7003893 0.85 KCNH2 (0.45) CYP2D6SLC6A2SLC6A4SLC6A3KDM1A
SCHEMBL7003889 0.85 KCNH2 (0.45) CYP2D6SLC6A2SLC6A4SLC6A3KDM1A
SCHEMBL7092112 0.85 KCNH2 (0.45) CYP2D6SLC6A2SLC6A4SLC6A3KDM1A
SCHEMBL12971950 0.82 HTR2A (0.59) KDM1AKCNH2KDM1BMAOBMAOA
SCHEMBL6997479 0.82 HTR2A (0.59) KDM1AKCNH2KDM1BMAOBMAOA
SCHEMBL6997477 0.82 HTR2A (0.59) KDM1AKCNH2KDM1BMAOBMAOA
SCHEMBL7004268 0.82 KDM1A (0.48) CYP3A4CYP2D6SLC6A2SLC6A3KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996621-B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS ASTRAZENECA AB (SE) 2003-10-01 EP disclosed
EP-0996621-A1 NOVEL COMPOUNDS Astra Pharmaceuticals Limited (GB) 2000-05-03 EP disclosed
WO-1999005143-A1 NOVEL COMPOUNDS ASTRA PHARMACEUTICALS LTD. (GB) 1999-02-04 WO disclosed